Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Medtronic (NYSE:MDT) is currently navigating a landscape marked by both promising innovations and significant challenges.

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Shares of Medtronic PLC MDT shed 1.64% to $88.63 Tuesday, on what proved to be an all-around mixed trading session for the ...